1.0 Abstract
Prevalence of Sickle Cell Disease is high in Africa, with significant public health effects to the affected countries. Many of the countries with the highest prevalence of the disease also have poor health care system, high burden of infectious diseases with many other competing healthcare priorities. Though, considerable efforts have been done to implement newborn screening for Sickle Cell Disease programs in Africa but still coverage is low. Tanzania has one of the highest birth prevalence of children with Sickle Cell Disease in Africa. Also, it is one of many other African countries to implement pilot projects for Newborn Screening for Sickle Cell Disease to assess feasibility. Several efforts have been made afterwards to continue providing the screening services as well as comprehensive care for Sickle Cell Disease. Using qualitative methods, we conducted In- Depth Interviews and Focus Group Discussions with policy makers, health care providers and families to provide an analysis of their experiences and perspectives on efforts to expand and sustain Newborn Screening for Sickle Cell Disease and related comprehensive care services in the country. Findings have demonstrated both the opportunities and challenges in the implementation and sustainability of the services in low resource settings. A key area of strengthening is full integration of the services in countries’ health care systems to facilitate coverage, accessibility and affordability of the services. However, efforts at the local level to sustain the programs are encouraging and can be used as a model in other programs implemented in low resources settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DB research support was through student small grant at MUHAS. Commonwealth Scholarship Commission funded the DB to spend 1 year at Ethox centre where analysis and initial writing of this work started.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Muhimbili University of Health and Allied Sciences Research Ethics Committee (Ref. No. 2017- 10-20/ AEC/ Vol. XII/85). Consent was sought from all participants prior to the conduct of the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sharing not applicable as no datasets generated and/or analysed for this study. All data relevant to the study are included in the article.
Abbreviations
- AfriSickleNet
- Africa Sickle Cell Research Network
- ARRH
- Amana Regional Referral Hospital
- BMC
- Bugando Medical Centre
- DHH
- District Health Hospital
- FGDs
- Focus Group Discussions
- GAVI
- Global Alliance for Vaccine and Immunization
- HCRL
- Hematology Clinical Research Laboratory
- HIV
- Human Immunodeficiency Virus
- HCP
- Health Care Providers
- HCF
- Health Care Facilities
- IDIs
- In- Depth Interviews
- LMICs
- Low Middle Income Countries
- MNH
- Muhimbili National Hospital
- MRRH
- Mwananyamala Regional Referral Hospital
- NBS
- Newborn Screening
- POCT
- Point of Care Testing
- RRH
- Regional Referral Hospitals
- SCD
- Sickle Cell Disease
- SCP
- Sickle Cell Program
- SCPCT
- Sickle Cell Patients Community of Tanzania
- SPARCO
- Sickle Pan African Research Consortium
- SYCF
- Sickle Cell Youth Foundation
- TANSCDA
- Tanzania Sickle Cell Disease Alliance
- TASIWA
- Tanzania Sickle Cell Warriors
- TRRH
- Temeke Regional Referral Hospital